Frees Fund
Beijingfreesvc.com
Overview
Frees Fund is a Chinese venture capital firm founded in 2015 that focuses on early-stage investments, while also participating in growth-stage and mid-to-late stage opportunities across the consumer/TMT, high technology, and biomedicine sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beijing Inflama Lab | Jul 2026 | Series B | Co-investor |
| Pyrotech Therapeutics | Jul 2026 | Early Funding | Co-investor |
| Jiajin Biopharmaceutical (Shanghai) Co., Ltd. | Jun 2026 | Series B++ | Co-investor |
| XellSmart | Apr 2026 | Series C Extension | Co-investor |
| AeroBand | Mar 2026 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
